Concepedia

Marek Pruszyński

MP

27

Publications

1.5K

Citations

22

H-Index

2006

Active since

Affiliations

Instytut Chemii i Techniki Jądrowej(Current)

Duke Medical Center

University of Warsaw

Joint Research Centre

Vrije Universiteit Brussel

Marek Pruszyński is an author at Instytut Chemii i Techniki Jądrowej specializing in natural sciences, engineering, and nuclear medicine.

ORCID

Top concepts

Publications per year

2006–2022

27

Publications

27

131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

Matthias D’Huyvetter, Jens De Vos, Catarina Xavier et al. · Clinical Cancer Research · 2017 · 173 citations · Full text

Evaluation of an Anti-HER2 Nanobody Labeled with <sup>225</sup>Ac for Targeted α-Particle Therapy of Cancer

Marek Pruszyński, Matthias D’Huyvetter, Frank Bruchertseifer et al. · Molecular Pharmaceutics · 2018 · 113 citations

Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody

Marek Pruszyński, Eftychia Koumarianou, Ganesan Vaidyanathan et al. · Nuclear Medicine and Biology · 2012 · 103 citations · Full text

, , +4

Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application

Marek Pruszyński, Natalia S. Loktionova, D. V. Filosofov et al. · Applied Radiation and Isotopes · 2010 · 102 citations

, , +6

Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer

Ł. Dziawer, Agnieszka Majkowska‐Pilip, Damian Gaweł et al. · Nanomaterials · 2019 · 97 citations · Full text

Rows per page

1–5 of 27